Daniel Wacker
Biographic Data
| ID | 7449137 |
|---|---|
| NAME | Daniel Wacker |
| GIVEN NAMES | Daniel |
| FAMILY NAME | Wacker |
| SIGNATURE | WACKER D |
| AFFILIATIONS | University of North Carolina Health Care |
| ORCID | 0009-0006-8649-6482 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016–2024
Gabapentin prescription use has increased across the United States since the late 2000s. Concerns of potential misuse and growing overdose involvement have led to the passage of jurisdiction-specific policies targeting gabapentin prescribing; however, the current legal landscape of these policies is not well documented or understood. We conducted a comprehensive, longitudinal analysis of policies related to scheduling or required prescription dru…
No prominent works on this page.
A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016–2024
Gabapentin prescription use has increased across the United States since the late 2000s. Concerns of potential misuse and growing overdose involvement have led to the passage of jurisdiction-specific policies targeting gabapentin prescribing; however, the current legal landscape of these policies is not well documented or understood. We conducted a comprehensive, longitudinal analysis of policies related to scheduling or required prescription dru…
Controlled substance (1 works) · Drug (1 works) · Gabapentin (1 works) · Medical prescription (1 works) · Opioid Use Disorder Treatment (1 works) · Pharmaceutical Practices and Patient Outcomes (1 works) · Poisoning and overdose treatments (1 works) · Prescription drug (1 works) · Schedule (1 works) · Workload (1 works)